MDCO insider buy notable for two reasons: i) the amount ($10.1M); and ii) the buyer, Fredric Eshelman, who founded two biotech companies that were sold at nice premiums (PPDI and FURX).
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.